Not Yet RecruitingNCT06090422

Ketamine for Combined Depression and Alcohol Use Disorder

This study is not yet recruiting. It focuses on depression and currently lists study information in Global.

Depression, Alcohol Use DisorderDrugFrom 18 Years to 65 Years

Need help deciding?

Ask HopeStage to review this study with me

Study reference: NCT06090422. HopeStage can help you review the study, but cannot decide medical eligibility.

In plain English

Key information made simple

This study is comparing Ketamine Hydrochloride with Control group for people with Depression or Alcohol Use Disorder. Participants receive Ketamine Hydrochloride or Control group and complete study visits and assessments. Some participants may receive Control group instead of the study treatment, and direct benefit is not guaranteed.

What to expect

Your next step

The official record does not clearly spell out the visit format, but it appears to be coordinated directly by the research team. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and pregnancy or breastfeeding. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Before joining

Questions to ask before joining

What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?

Study clarity

Things to check before joining

Study start dateEstimated: January 1, 2025

Time commitment: multiple visits or assessments
Study phase: Not available
Enrollment: Not available
Recruitment status: Not Yet Recruiting
Sponsor: University Hospital of North Norway
Sponsor type: Hospital / academic medical center
Main activity: medication or study treatment
Intervention: Not available
Source: Official registry link

Want help reviewing this study?

Public study data

Key study information

Official title: Ketamine for Combined Depression and Alcohol Use Disorder
Condition: Depression, Alcohol Use Disorder
Study status: Not Yet Recruiting
Sponsor / lead affiliation: University Hospital of North Norway
Location / country: Global
Registry: ClinicalTrials.gov
External trial ID: NCT06090422

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Official title: Ketamine for Combined Depression and Alcohol Use Disorder
Source: ClinicalTrials.gov
Official registry link: Open official registry
External trial ID: NCT06090422

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is Ketamine for Combined Depression and Alcohol Use Disorder?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with a control group. Direct benefit is not guaranteed.

Who is behind this study, and what type of sponsor is it?

This study is sponsored by University Hospital of North Norway. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.

What does participation involve, what phase is it, and what should I ask about safety?

This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Where can I verify the study details?

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me